Jeffrey M. Leiden
Executive Chairman at Vertex Pharmaceuticals; Director at Odyssey Therapeutics. Based in Boston, Massachusetts.
- Rank
- 4636th of 14,452
- Companies held
- 2
- Largest holding
- VRTX, 78.7% of total
- Latest SEC filing
- May 11, 2026
- Listed but not counted
- $581K
What the $23.3M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals VRTX Common Stock | Directly | 34,797 | $520.66 | $18.1M | 77.8% | Form 4, Feb 24, 2026 |
| Odyssey Therapeutics ODTX Common Stock | Directly | 270,198 | $18.34 | $5.0M | 21.3% | Form 4, May 8, 2026 |
| Vertex Pharmaceuticals VRTX Common Stock | Indirectly (see filing footnote) | 440 | $520.66 | $229K | 1.0% | Form 4, Feb 24, 2026 |
Share counts are the amounts Jeffrey M. Leiden reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Jeffrey M. Leiden's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Odyssey Therapeutics ODTX Common Stock | Through Racing Beach Ventures LLC Held by a company or fund the insider manages | 31,661 | $18.34 | $581K | — | Form 4, May 11, 2026 |
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 8, 2026 | Bought | ODTX | 5,000 | $20.00 | $100K | View |
| Dec 3, 2025 | Sold | VRTX | 7,899 | $445.56 | $3.5M | View |
| Dec 3, 2025 | Sold | VRTX | 10,360 | $453.34 | $4.7M | View |
| Dec 3, 2025 | Sold | VRTX | 15,681 | $452.20 | $7.1M | View |
| Dec 3, 2025 | Sold | VRTX | 5,809 | $451.20 | $2.6M | View |
| Dec 3, 2025 | Sold | VRTX | 5,880 | $449.84 | $2.6M | View |
| Dec 3, 2025 | Sold | VRTX | 2,320 | $448.78 | $1.0M | View |
| Dec 3, 2025 | Sold | VRTX | 1,152 | $447.05 | $515K | View |
| Dec 3, 2025 | Sold | VRTX | 2,070 | $455.22 | $942K | View |
| Dec 3, 2025 | Sold | VRTX | 4,469 | $440.40 | $2.0M | View |
| Dec 3, 2025 | Sold | VRTX | 1,320 | $441.26 | $582K | View |
| Dec 3, 2025 | Sold | VRTX | 2,469 | $443.21 | $1.1M | View |
| Dec 3, 2025 | Sold | VRTX | 4,352 | $444.36 | $1.9M | View |
| Nov 14, 2025 | Sold | VRTX | 40 | $442.00 | $18K | View |
| Nov 14, 2025 | Sold | VRTX | 32,234 | $440.30 | $14.2M | View |
| Nov 14, 2025 | Sold | VRTX | 21,330 | $441.35 | $9.4M | View |
| Nov 13, 2025 | Sold | VRTX | 18,528 | $440.22 | $8.2M | View |
| Nov 13, 2025 | Sold | VRTX | 1,160 | $441.05 | $512K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4633 | Glen W. Hauenstein President, Delta Air Lines. Atlanta, GA | $23.3M |
| 4634 | Aaron Freidin Chief Financial Officer, GRAIL. Sunnyvale, CA | $23.3M |
| 4635 | Jason P. Wells President & CEO, CenterPoint Energy. Houston, TX | $23.3M |
| 4636 | Jeffrey M. Leiden Executive Chairman, Vertex Pharmaceuticals. Boston, MA | $23.3M |
| 4637 | Christopher R. Fenimore EVP Finance CFO, Regeneron Pharmaceuticals. Tarrytown, NY | $23.3M |
| 4638 | Junyuan Jerry Wang CEO, ANHEART THERAPEUTICS LTD., Nuvation Bio. New York, NY | $23.3M |
| 4639 | Kara Lynn Sprague EVP & GM, Application Services, F5. Westminster, CO | $23.3M |
Other Vertex Pharmaceuticals insiders
All VRTX insiders- Reshma Kewalramani$45.0MCEO & President. #2739 overall
- Amit Sachdev$38.5MEVP Chief Patient & Ext Af Off. #3089 overall
- Stuart A. Arbuckle$33.1MEVP, COO. #3307 overall
- Ourania Tatsis$27.9MEVP, Chief Reg. & Quality Off.. #4004 overall
- Bruce I. Sachs$20.3MDirector. #5124 overall
- David Altshuler$18.0MEVP, Chief Scientific Officer. #5632 overall
Questions
How much stock does Jeffrey M. Leiden own?
Jeffrey M. Leiden holds $23,301,928 in listed stock based on SEC filings and current prices, mostly Vertex Pharmaceuticals (VRTX). That ranks 4636th on the Stock Rich List.
Is this Jeffrey M. Leiden's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Jeffrey M. Leiden last buy or sell stock?
The most recent open-market trade on file is a purchase of 5,000 ODTX shares on May 8, 2026 at $20.00.